Document is current
Any future updates will be listed below
-
Authors
Parvan, Reza
AbouMsallem, Joseph Pierre
Meijers, Wouter C.
de Boer, Rudolf A. https://orcid.org/0000-0002-4775-9140
- License Information
-
More Information
Article History
First Online: 12 November 2025
Competing interests
: R.A.d.B.’s institution has received research grants and/or fees from Alnylam, AstraZeneca, Abbott, Bristol-Myers Squibb, NovoNordisk and Roche; R.A.d.B. has had speaker engagements with and/or received fees from and/or served on advisory boards for Abbott, AstraZeneca, Bristol Myers Squibb, NovoNordisk, Roche and Zoll and has received travel support from Abbott and NovoNordisk. W.C.M. has received speaker/advisory board fees from Daiichi Sankyo, Novartis and Astellas.
